Caregiving is a tough job that affects everyone, regardless of their celebrity or financial status. That's why some big names ...

Swiss pharmaceutical giant Roche is set to explore the potential of its experimental drug, Trontinemab, in delaying or ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new ...

Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases like ...

A tiny region Locus Coeruleus located in your brainstem, acts like a powerful memory reset button. It's pivotal for forming ...

Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025 </str ...

Dementia, a condition impacting memory and cognitive functions, poses a significant global health challenge. Research ...

Dr Emmanuel Iwuozo, a consultant neurologist at the Benue State University Teaching Hospital in Makurdi, Benue State, and ...

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific understanding of ...

Alpha Cognition's ZUNVEYL targets Alzheimer's with improved tolerability over existing galantamine therapies. Read why I rate ...